论文信息 - Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD. - 字舞流文

Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD.

James E. Novak | S. Hemmerich | L. Szczech | A. Besarab | R. Leong | T. Neff | K. P. Yu | R. Provenzano | K. Saikali | Tyson T. Lee | B. Roberts | J. Cangiano | J. E. Novak | Chao H Sun | Susan Diamond | J. Durham | J. Aiello